Craig Collard

Craig Collard

Chief Executive OfficeratHeron Therapeutics, Inc. /De/· In proxies 2022–2025

Pay in FY2025+147% from the year before · Heron Therapeutics, Inc. /De/ stock -15.0% the same year

Craig Collard was paid $3.5M in FY2025 (Dec), up 147%. Heron Therapeutics, Inc. /De/ stock fell 15.0% that year.

Pay$100 in the stock at the end of FY21 → $14
Pay is from the Summary Compensation Table of each Heron Therapeutics, Inc. /De/ proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Heron Therapeutics, Inc. /De/Public company · 4 yr
    • Chief Executive Officer2022 – Present · 4 yrStock in role -97%
  2. TerrAscend Corp.Public company · 8 yr
    • Director2018 – Present · 8 yrNo stock prices for these years
  3. Sierra Oncology, Inc.Public company · 2 yr
    • Director2020 – 2022 · 2 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?